These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 8500889)
21. Structural investigation of Borrelia burgdorferi OspB, a bactericidal Fab target. Becker M; Bunikis J; Lade BD; Dunn JJ; Barbour AG; Lawson CL J Biol Chem; 2005 Apr; 280(17):17363-70. PubMed ID: 15713683 [TBL] [Abstract][Full Text] [Related]
22. Complement resistance in Borrelia burgdorferi strain 297: outer membrane proteins prevent MAC formation at lysis susceptible sites. Patarakul K; Cole MF; Hughes CA Microb Pathog; 1999 Jul; 27(1):25-41. PubMed ID: 10371707 [TBL] [Abstract][Full Text] [Related]
23. Activation of complement pathways by univalent antibody derivatives with intact Fc zones. Watts HF; Anderson VA; Cole VM; Stevenson GT Mol Immunol; 1985 Jul; 22(7):803-10. PubMed ID: 3849671 [TBL] [Abstract][Full Text] [Related]
24. Borreliacidal activity of sera from hamsters infected with the Lyme disease spirochete. Lovrich SD; Callister SM; Schmitz JL; Alder JD; Schell RF Infect Immun; 1991 Aug; 59(8):2522-8. PubMed ID: 1855973 [TBL] [Abstract][Full Text] [Related]
25. Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates. Kraiczy P; Skerka C; Kirschfink M; Zipfel PF; Brade V Int Immunopharmacol; 2001 Mar; 1(3):393-401. PubMed ID: 11367524 [TBL] [Abstract][Full Text] [Related]
26. Borrelia burgdorferi infection and immunity in mice deficient in the fifth component of complement. Bockenstedt LK; Barthold S; Deponte K; Marcantonio N; Kantor FS Infect Immun; 1993 May; 61(5):2104-7. PubMed ID: 8478100 [TBL] [Abstract][Full Text] [Related]
27. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. Joiner KA; Scales R; Warren KA; Frank MM; Rice PA J Clin Invest; 1985 Nov; 76(5):1765-72. PubMed ID: 3932472 [TBL] [Abstract][Full Text] [Related]
28. Animal and human antibodies reactive with the outer surface protein A and B of Borrelia burgdorferi are borreliacidal, in vitro, in the presence of complement. Sambri V; Armati S; Cevenini R FEMS Immunol Med Microbiol; 1993 Jun; 7(1):67-71. PubMed ID: 8364524 [TBL] [Abstract][Full Text] [Related]
29. Lyme arthritis: oligoclonal anti-Borrelia burgdorferi IgG antibodies occur in joint fluid and serum. Cruz M; Hansen K; Ernerudh J; Steere AC; Link H Scand J Immunol; 1991 Jan; 33(1):61-71. PubMed ID: 1996408 [TBL] [Abstract][Full Text] [Related]
30. Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Leijh PC; van den Barselaar MT; Daha MR; van Furth R Infect Immun; 1981 Sep; 33(3):714-24. PubMed ID: 7026443 [TBL] [Abstract][Full Text] [Related]
31. Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans. Boxx GM; Nishiya CT; Kozel TR; Zhang MX Mol Immunol; 2009 Jan; 46(3):473-80. PubMed ID: 19038459 [TBL] [Abstract][Full Text] [Related]
32. Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Alitalo A; Meri T; Rämö L; Jokiranta TS; Heikkilä T; Seppälä IJ; Oksi J; Viljanen M; Meri S Infect Immun; 2001 Jun; 69(6):3685-91. PubMed ID: 11349031 [TBL] [Abstract][Full Text] [Related]
33. Protection elicited by native outer membrane protein Oms66 (p66) against host-adapted Borrelia burgdorferi: conformational nature of bactericidal epitopes. Exner MM; Wu X; Blanco DR; Miller JN; Lovett MA Infect Immun; 2000 May; 68(5):2647-54. PubMed ID: 10768956 [TBL] [Abstract][Full Text] [Related]
34. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia. Brown EJ; Hosea SW; Hammer CH; Burch CG; Frank MM J Clin Invest; 1982 Jan; 69(1):85-98. PubMed ID: 7054244 [TBL] [Abstract][Full Text] [Related]
35. Complement activation and sensitizing antibodies in Lyme borreliosis. A microbial adherence immobilization assay for Borrelia burgdorferi (MAIA-BB). Cacciapuoti B; Ciceroni L; Fontana L; Perricone R Zentralbl Bakteriol; 1993 Feb; 278(1):102-11. PubMed ID: 8518505 [TBL] [Abstract][Full Text] [Related]
36. Antibody-dependent alternative pathway killing of Haemophilus influenzae type b. Steele NP; Munson RS; Granoff DM; Cummins JE; Levine RP Infect Immun; 1984 May; 44(2):452-8. PubMed ID: 6609128 [TBL] [Abstract][Full Text] [Related]
37. A monoclonal antibody to OspA inhibits association of Borrelia burgdorferi with human endothelial cells. Comstock LE; Fikrig E; Shoberg RJ; Flavell RA; Thomas DD Infect Immun; 1993 Feb; 61(2):423-31. PubMed ID: 7678585 [TBL] [Abstract][Full Text] [Related]
38. Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato. Wilske B; Fingerle V; Preac-Mursic V; Jauris-Heipke S; Hofmann A; Loy H; Pfister HW; Rössler D; Soutschek E Med Microbiol Immunol; 1994 Feb; 183(1):43-59. PubMed ID: 8202030 [TBL] [Abstract][Full Text] [Related]
39. Isolation of moderately infectious Borrelia burgdorferi sensu stricto from attenuated cultures by using complement-mediated, antibody-dependent lysis selection technique in a mammalian tissue co-culture system. Sen E; Schell RF Microbes Infect; 2003 Aug; 5(10):869-78. PubMed ID: 12919855 [TBL] [Abstract][Full Text] [Related]
40. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. Hellwage J; Meri T; Heikkilä T; Alitalo A; Panelius J; Lahdenne P; Seppälä IJ; Meri S J Biol Chem; 2001 Mar; 276(11):8427-35. PubMed ID: 11113124 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]